Your browser doesn't support javascript.
loading
A network meta-analysis on the efficacy of HER2-targeted agents in combination with taxane-containing regimens for treatment of HER2-positive metastatic breast cancer.
Xie, Bao-Jie; Zhu, Li-Na; Ma, Can; Li, Ji-Bin; Dong, Lei; Zhu, Zhong-Ning; Ding, Tao; Gu, Xin-Shun.
Afiliação
  • Xie BJ; Department of Radiology, The Fourth Hospital of Hebei Medical University, 12, Jiankang Road, Shijiazhuang, 050011, China.
  • Zhu LN; Department of Radiology, The Fourth Hospital of Hebei Medical University, 12, Jiankang Road, Shijiazhuang, 050011, China.
  • Ma C; Department of Oncology, The First Hospital of Shijiazhuang, 36, Fanxi Road, Shijiazhuang, 050011, China.
  • Li JB; Department of Obstetrics and Gynecology Two Branch, Hebei General Hospital, 348 Heping West Road, Shijiazhuang, 050031, China.
  • Dong L; Department of Pharmacy, Hebei Children's Hospital, 133, Jianhua Street, Shijiazhuang, 050031, China.
  • Zhu ZN; Department of Pharmacology, Hebei Medical University, 361, Zhongshan East Road, Shijiazhuang, 050017, China.
  • Ding T; Department of Pathology, Hebei University of Chinese Medicine, 3, Xingyuan Road, Luquan, Shijiazhuang, 050200, China. domd2014@126.com.
  • Gu XS; Department of Cardiology, The Second Hospital of Hebei Medical University, 215, Heping West Road, Shijiazhuang, 050000, China. zzn1970@126.com.
Breast Cancer ; 27(2): 186-196, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31529262

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Breast Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Breast Cancer Ano de publicação: 2020 Tipo de documento: Article